News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Indigo Pharmaceuticals, Inc. Appoints Dennis R. Cryer as Chief Medical Officer


10/9/2007 9:09:49 AM

NEW YORK, Oct. 9, 2007 (PRIME NEWSWIRE) -- Manhattan-based Indigo Pharmaceuticals, Inc., a Paramount Biosciences-founded company committed to the development of new treatments for patients living with cardiovascular diseases and currently concentrating on peripheral arterial disease, announced today that Dennis R. Cryer, MD, FAHA has joined the company as its Chief Medical Officer. Dr. Cryer leaves a position as Vice President, External Medical Affairs at Bristol-Myers Squibb to lead clinical programs for Indigo Pharmaceuticals.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES